Sodium Sulfite vs Perfluorinated Compounds (PFAS): which is worse?

What is Sodium Sulfite?

Sodium sulfite is an inorganic sulfite salt used as a food preservative and antioxidant. It releases sulfur dioxide when it contacts water or acid, which acts as the active antimicrobial and antioxidant agent. Part of the broader sulfite family of food additives (including sulfur dioxide E220, sodium bisulfite E222, and others).

What is Perfluorinated Compounds (PFAS)?

Per- and polyfluoroalkyl substances (PFAS) are a large family of synthetic chemicals characterized by extremely strong carbon-fluorine bonds. They are used in food packaging (grease-resistant coatings), non-stick cookware (PTFE/Teflon), food processing equipment, firefighting foam, and many industrial applications. The 'forever chemicals' moniker reflects their extreme environmental persistence.

Documented risks

Sodium Sulfite: Sulfites are among the more significant food allergy/intolerance triggers. An estimated 1 in 100 people, and up to 5% of asthmatics, are sulfite-sensitive. Reactions can include urticaria, angioedema, bronchospasm, and in severe cases anaphylaxis. Sulfite-induced asthma can be severe; several deaths attributable to sulfite-triggered anaphylaxis have been documented. The FDA banned sulfites from fresh produce and restaurant salad bars in 1986 after several deaths and severe reactions were linked to sulfite-treated salads. FDA mandates that sulfite content above 10 ppm be declared on US food labels. All forms of sulfites (E220-E228) share these sensitization concerns.

Perfluorinated Compounds (PFAS): PFAS are among the most extensively studied and harmful groups of synthetic chemicals in the modern environment. Their unique carbon-fluorine bond stability means they do not break down in the environment or in human body tissues — contributing to bioaccumulation over a lifetime. Health effects documented in human epidemiological studies include: - Cancer: PFOA (perfluorooctanoic acid) and PFOS (perfluorooctanesulfonic acid) have been associated with kidney cancer, testicular cancer, thyroid cancer, bladder cancer, and non-Hodgkin lymphoma in occupationally exposed workers and community members with contaminated drinking water. IARC classified PFOA as Group 1 (human carcinogen) in 2023 and PFOS as Group 2B. - Endocrine disruption: PFAS disrupt thyroid hormone signaling and sex hormone balance. Multiple studies find associations between PFAS exposure and hypothyroidism, early puberty in girls, and reduced sperm quality. - Immune suppression: studies have found that PFAS exposure is associated with reduced vaccine response in children and adults, suggesting PFAS may impair immune function. - Developmental effects: prenatal PFAS exposure has been associated with lower birth weight, developmental delays, and reduced immune response in infants. - Cholesterol: PFAS exposure consistently raises LDL cholesterol levels, increasing cardiovascular disease risk. The 2023 EPA MCLG (maximum contaminant level goal) for PFOA and PFOS is zero — reflecting the agency's conclusion that there is no safe level. The EPA set enforceable MCLs in drinking water in 2024. The DuPont/3M PFOA/PFOS contamination of drinking water in communities near Teflon manufacturing facilities led to a $671 million settlement (DuPont/Chemours, 2017) and $10.3 billion 3M settlement (2023) — among the largest environmental contamination settlements in history.